Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. Statins and cancer risk
Your Article Summary
Informed Consent and Shared Decision-Making: A Requirement to Disclose to Patients Off-Label Prescriptions
PLoS Medicine, 11/14/08
Wilkes M et al. - Patients need information about off-label uses to make well-informed health care decisions. The legal doctrine of informed consent should be expanded to require disclosure of off-label prescribing where the drug has not been proven safe and effective for the condition, especially where scientific evidence is inadequate and risks are substantial or unknown. The ethical requirement of SDM should be expanded to require discussions of off-label uses under the same circumstances. Requiring disclosure will protect patient autonomy and educate patients about alternatives and risks, leading to improved health care decisions.
Related Articles
Prescription medication borrowing and sharing - Risk factors and management
Australian Family Physician, 10/05/09
Relevance Score: 46%
Development and Reliability of Items Measuring the Nonmedical Use of Prescription Drugs for the Youth Risk Behavior Survey: Results From an Initial Pilot Test
Journal of School Health, 10/26/09
Relevance Score: 44%
Strong E-Prescribing Growth for Walgreens
HealthDataManagement, 11/13/09
Relevance Score: 43%
Partnership for Prescription Assistance Celebrates Milestone Helping More Than 6 Million Uninsured Patients
PhRMA, 10/23/09
Relevance Score: 43%
Prescription writing for diabetes: compliance with good practice
Nurse Prescribing, 10/12/09
Relevance Score: 43%
Today in Other Drugs...keeping you current
Receive free subspecialty "5-minute updates" via email
Magnesium sulphate in the treatment of acute asthma: evaluation of current practice in adult emergency departments
Emergency Medicine Journal, 12/02/09
Clinical Studies of Liraglutide, a Novel, Once-Daily Human Glucagon-Like Peptide-1 Analog for Improved Management of Type 2 Diabetes Mellitus
Pharmacotherapy, 12/02/09
The Intersection of Safety and Adherence: New Incretin-Based Therapies in Patients with Type 2 Diabetes Mellitus
Pharmacotherapy, 12/02/09
Today in Patient Counseling...keeping you current
Receive free subspecialty "5-minute updates" via email
Vascular Access-Related Bloodstream Infections in First Nations, Community and Teaching Canadian Dialysis Units, and Other Centre-Level Predictors
Nephron: Clinical Practice, 12/02/09
Unexpected Occurrence of Xeroderma Pigmentosum in an Uncle and Nephew
Archives of Dermatology, 11/25/09
Male involvement in antenatal HIV counseling and testing: exploring mens perceptions in rural Malawi
AIDS Care, 11/23/09
Sponsor
Article Search
Sponsor


See Latest Articles


